SY
HealthcareSo-Young International Inc.
$2.73
+$0.06 (+2.25%)
Jan 5, 2026
Price History (1Y)
Analysis
So-Young International Inc. is a healthcare company operating in the health information services industry. The company has a significant scale with a market capitalization of $272.01M, annual revenue of $1.43B, and approximately 1800 employees. The company's financial performance indicates profitability challenges, with negative net income and EBITDA of -$741M and -$176M respectively. However, it maintains a gross margin of 51.6% and has a substantial cash reserve of $875.25M to offset its debt of $265.59M. The current ratio stands at 2.20, indicating relatively good short-term liquidity. The company's valuation is characterized by a forward P/E ratio of 21.17, which may be influenced by its revenue growth rate of 4.0% year-over-year and a beta value of 2.07. The dividend yield is not applicable as the company does not pay dividends.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About So-Young International Inc.
So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users access to medical aesthetic knowledge, community support and reservation options for treatment with medical professionals, and medical aesthetic institutions; Weixin mini program to explore treatment options, check prices, schedule appointments, participate in online consultations, and track follow-ups; and medical aesthetic community content through its website soyoung.com. Its aesthetic centers offer non-invasive and minimally invasive procedures, including device-based options, such as thread lifts, intense pulsed light, ultrasound facelifts, picosecond lasers, and body contouring treatments, as well as injectable treatments, including skin boosters, hyaluronic acid-based products, botox, and type I and type III collagen. In addition, the company engages in the research and development, production, sale, and distribution of light therapy devices, including excimer laser systems, UV excimer therapy devices, LED and red-light therapy systems, and advanced laser and intense pulsed light technologies; surgical laser devices, including carbon dioxide laser machines, multi-wavelength and semiconductor laser systems, and hydrodynamic-assisted liposuction systems, as well as pneumatic liquid spray devices. Further, it offers injectable products; sales and technical, maintenance, installation, operational training, error reporting, maintenance, and equipment packaging services; consumption healthcare services, including dermatology, dentistry and orthodontics, physical examinations, gynecology, and postnatal care; reservation services; and content management through beauty diaries, short-form videos, treatment reviews, featured articles, and chat messages. The company was founded in 2013 and is headquartered in Chaoyang, China.
Visit website →Key Statistics
- Market Cap
- $272.01M
- P/E Ratio
- N/A
- 52-Week High
- $6.28
- 52-Week Low
- $0.67
- Avg Volume
- 1.06M
- Beta
- 2.07
Company Info
- Industry
- Health Information Services
- Exchange
- NCM
- Country
- China
- Employees
- 1,800